Abstract
e23106Background: Tumor resident myeloid cells (MCs) are instrumental to cancer progression. Consequently, MCs are an emerging therapeutic target in many cancers. However, the mechanisms by which t...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have